FDA Approved: LEVETIRACETAM ER — Original Application (Westminster Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved Westminster Pharmaceuticals' generic extended-release levetiracetam tablet (LEVETIRACETAM ER) under an Original Abbreviated New Drug Application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Juvenile Myoclonic Epilepsy
• Partial-onset Seizures
• Seizure Disorders

Drugs mentioned

• LEVETIRACETAM ER (LEVETIRACETAM)

Snippet

ORIG AP for LEVETIRACETAM ER (LEVETIRACETAM)